Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ![WX -"lW
sDnHd9v<?t
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© #5GIO
JGPLVw
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© BM*9d%m^
[B9'/:
1.Co-stimulators (or co-stimulating molecules) G l+[|?N
I]P'wav~O
2.NK-kB orn9;|8q
$x5P
5^Y
3.Immunoglobulin superfamily D3V5GQ\=
3jPua)=p
4.antigen-presenting cell (APC) Uw^`_\si
Z]l<,m
5.death domain y0qrl4S)v
hK9Trr wau
6.CCR and CXCR kH1hsDe|&y
Pk[:+. f(
7.Lectin (or mitogen) U>6MT@\
Z8nj9X$
8.Clusters of differentiation, CD) \|nF55W [
d_=@1JM>
9.B7 family V0 x[sEW
%se4aeOrX
10.Cytotoxic T lymphocyte, CTL) 9tsI1]1[m
/%|JP{
11.IL-15 and IL-15 receptor (IL-15R) 'Ca6cm3Tg
m8eyAvi6
12.MHC restriction
^pZ1uN!b
Twyx(~'&R
13.Affinity-chromatography c^vPd]Ed
;LE4U OK
14.Cyctosprin A, CsA $E3-</ f
:b)IDcW&j:
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ~K}iVX
$X8(OS5d'
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© zY~
^;jJVYx-PP
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 yQE|FbiA
lo*OmAF
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 0"7%*n."2
v+uq
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ f =@'F=
m3W:\LTTp
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© {Q],rv|;
3qJOE6[}%
ÃâÒßѧרҵ£º li'h&!|]
4?Pdld
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ r09gB#K4
' i5 VU4?K
Ïû»¯ÄÚ¿Æ£º 8*7t1$
0_'(w;!wq:
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ZoX24C
'
eewhT^
ѪҺ²¡Ñ§×¨Òµ£º e RY2.!
<xpOi&l
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿